Selenium deficiency is associated with insulin resistance in patients with hepatitis C virus-related chronic liver disease

Nutrition Research

Volumn 31, Issue 11, 2011, Pages 829-835

  Himoto, Takashi ^a   Yoneyama, Hirohito ^a   Kurokohchi, Kazukata ^a   Inukai, Michio ^a   Masugata, Hisashi ^a   Goda, Fuminori ^a   Haba, Reiji ^a   Watababe, Seishiro ^b   Kubota, Satoru ^c   Senda, Shoichi ^a   Masaki, Tsutomu ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^c Medico Consl   (Japan)

Author keywords

Chronic liver disease; Glutathione peroxidase; Hepatic fibrosis; Hepatitis C virus; Insulin resistance; Selenium

Indexed keywords

ALBUMIN; GLUTATHIONE PEROXIDASE; SELENIUM; ZINC;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENETIC VARIABILITY; HEPATITIS C; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELENIUM DEFICIENCY; VIRUS LOAD; ZINC BLOOD LEVEL;

ADULT; AGED; FEMALE; GLUTATHIONE PEROXIDASE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RNA, VIRAL; SELENIUM; VIRAL LOAD; ZINC;

EID: 82455194581     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2011.09.021     Document Type: Article

References (54)

1. Burk R.F., Hill K.E., Motley A.K. Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 2003, 133:1517s-1520s.
2. Stadman T.C. Biosynthesis and function of selenocystein-containing enzymes. J Biol Chem 1991, 266:16257-16260.
3. Burk R.F., Hill K.E. Regulation of selenoproteins. Ann Rev Nutr 1993, 13:65-81.
4. Brown K.M., Arthur J.R. Selenium, selenoprotein and human health: a review. Public Health Nutr 2001, 4:593-599.
5. Bellinger F.P., Raman A.V., Reeves M.A., Berry M.J. Regulation and function of selenoproteins in human disease. Biochem J 2009, 422:11-22.
6. Li G.S., Wang F., Kang D., Li C. Keshan disease: an endemic cardiomyopathy in China. Hum Pathol 1985, 16:602-609.
7. Moreno-Reyes R., Suetens C., Mathieu F., et al. Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med 1998, 339:1112-1120.
8. Välimäki M.J., Hariu K.J., Ylikahri R.H. Decrease serum selenium in alcoholics-a consequence of liver dysfunction. Clin Chim Acta 1983, 130:291-296.
9. Aaseth J., Smith-Kielland A., THomassen Y. Selenium, alcohol and liver diseases. Ann Clin Res 1986, 18:43-47.
10. Tanner A.R., Bantock I., Hinks L., Lloyd B., Turner N.R., Wright R. Depressed selenium and vitamin E levels in an alcoholic population. Possible relationship to hepatic injury through increased lipid peroxidation. Dig Dis Sci 1986, 31:1307-1312.
11. McClain C.J., Marsano L., Burk R.F., Bacon B. Trace metals in liver disease. Semin Liver Dis 1991, 11:321-339.
12. Thuluvath P.J., Triger D.R. Selenium in chronic liver disease. J Hepatol 1992, 14:176-182.
13. Burk R., Early D.S., Hill K.E., Palmer I.S., Boeglin M.E. Plasma selenium in patients with cirrhosis. Hepatology 1998, 27:794-798.
14. Casaril M., Stanzial A.M., Gabrielli G.B., et al. Serum selenium in liver cirrhosis: correlation with markers of fibrosis. Clin Chim Acta 1989, 18:221-228.
15. Thuluvath P.J., Triger D.R. Selenium in primary biliary cirrhosis. Lancet 1987, 2(8582):219.
16. Navarro M., Lopez H., Perez V., et al. Serum and urine selenium concentrations as indications of body status in patients with diabetes mellitus. Sci Total Environ 1999, 22:79-85.
17. Kljai K., Runje R. Selenium and glycogen levels in diabetic patients. Biol Trace Elem Res 2001, 83:223-229.
18. Kinlaw W.B., Levine A.S., Morley J.E., Silvis S.E., McClain C.J. Abnormal zinc metabolism in type II diabetes mellitus. Am J Med 1982, 75:273-277.
19. Aguilar M.V., Saavedra P., Arrieta F.J., Mateos C.J., Gonzalez M.J., et al. Plasma mineral content in type 2 diabetic patients and their association with metabolic syndrome. Ann Nutr Metab 2007, 51:402-406.
20. Davies S., McLaren H.J., Hunnisett A., et al. Age-related decrease in chromium levels in 51,655 hair, sweat, and serum samples from 40,872 patients-implications for the prevention of cardiovascular disease and type II diabetes mellitus. Metabolism 1997, 46:469-473.
21. Jain S.K., Pemberton P.W., Smith A., et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002, 36:805-811.
22. Ko W.S., Guo C.H., Yeh M.S., et al. Blood micronutrient, oxidative stress, and viral load in patients with chronic hepatitis C. World J Gastroenterol 2005, 11:4697-4702.
23. Gonzales-Reimers E., Martin-Gonzalez M.C., Aleman-Valls M.R., et al. Relative and combined effects of chronic alcohol consumption and HCV infection on serum zinc, copper and selenium. Biol Trace Elem Res 2009, 132:75-84.
24. Lonardo A., Adinolfi L.E., Loria P., Carulli N., Ruggiero G., Day C.P. Steatosis and hepatitis C virus: mechanism and significance for hepatic and extrahepatic disease. Gastroenterology 2004, 126:586-597.
25. Hui J.M., Sud A., Farrell G.C., et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroenterology 2003, 125:1695-1704.
26. Negro F., Sanyal A.J. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathological data. Liver Int 2009, 26-37.
27. Kohgo Y., Ikuta K., Ohtake T., Torimoto Y., Kato J. Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance. World J Gastroenterol 2007, 13:4699-4706.
28. Lifschits M.D., Henkin R.I. Circadian variation in copper and zinc in man. J Appl Physiol 1971, 31:88-92.
29. Mattews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Trecher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985, 28:412-429.
30. Lau J.Y., Davis G.L., Kniffen J., et al. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993, 341:1501-1504.
31. Simmonds P., Alberti A., Alter H.J., et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 1994, 19:1321-1324.
32. Ichida F., Tsuji T., Omata M., et al. New Inuyama classification: new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun 1996, 6:112-119.
33. Miyazaki Y., Koyama H., Sasada Y., Satoh H., Nojiri M., Suzuki S. Dietary habits and selenium intake of residents in mountain and costal communities in Japan. J Nutr Sci Vitaminol 2004, 50:309-319.
34. Misra V., Misra S.P., Dwivedi M., Gupta S.C. Histomorphometric study of portal hypertensive enteropathy. Am J Clin Pathol 1997, 108:652-657.
35. Ding M., Potter J.J., Liu X., Torbenson M.S., Mezey E. Selenium supplementation decrease hepatic fibrosis in mice after chronic carbon tetrachloride administration. Biol Trace Elem Res 2010, 133:83-97.
36. Lim H.L., Myers B.M., Hamilton B.A., et al. Plasma glutathione concentration in patients with chronic hepatitis C virus infection. J Viral Hepat 1995, 2:211-214.
37. Johtatsu T., Andoh A., Kurihara M., et al. Serum concentration of trace elements in patients with Crohn's disease receiving enteral nutrition. J Clin Biochem Nutr 2007, 41:197-201.
38. Burk R.F., Hill K.E., Awad J.A., et al. Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: assessment of the roles of lipid peroxidation and selenoprotein P. Hepatology 1995, 21:561-569.
39. Motsenbocker M.A., Tappel A.L. A splenocystein-containing selenium transport protein in rat plasma. Biochem Biophys Acta 1982, 719:147-153.
40. Himoto T., Hosomi N., Nakai S., et al. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease. Scand J Gastroenterol 2007, 42:1078-1087.
41. Smith K.T., Failla M.L., Cousins R.J. Identification of albumin as plasma carrier for zinc absorption by perfused rat intestine. Biochem J 1978, 184:627-633.
42. Fartoux L., Poujol-Robert A., Guechot J., et al. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005, 54:1003-1008.
43. Furutani M., Nakashima T., Sumida Y., et al. Insulin resistance/β-cell function and serum ferritin level in non-diabetic patients with hepatitis C virus infection. Liver Int 2003, 23:294-299.
44. Himoto T., Yoneyama H., Deguchi A., et al. Insulin resistance derived from zinc deficiency in non-diabetic patients with chronic hepatitis C. Exp Ther Med 2010, 1:707-711.
45. Stapleton S.R. Selenium: an insulin-mimetic. Cell Mol Life Sci 2000, 57:1874-1879.
46. Ezaki O. The insulin-like effects of selenate in rat adipocytes. J Biol Chem 1996, 265:1124-1128.
47. Iizuka Y., Ueda Y., Yagi Y., Sakurai E. Significant improvement of insulin resistance of GK rats by treatment with sodium selenate. Biol Trace Elem Res 2010, 138:265-271.
48. Becker D.J., Reul B., Ozcelikay A.T., Buchet J.P., Henquin J.C., Brichard S.M. Oral selenate improves glucose homeostasis and partly reserves abnormal expression of liver glycolytic and gluconeogenic enzymes in diabetic rats. Diabetologia 1996, 39:3-11.
49. Steinbrenner H., Speckmann B., Pinto A., Sies H. High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J Clin Biochem Nutr 2011, 48:40-45.
50. Stranges S., Marshall J.R., Natarajan R., et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med 2007, 147:217-223.
51. Willett W.C., Polk B.F., Morris J.S., et al. Prediagnostic serum selenium and risk of cancer. Lancet 1983, 2(8342):130-134.
52. Dong Y., Lee S.O., Zhang H., et al. Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling. Cancer Res 2004, 64:19-22.
53. Clark L.C., Combs G.F., Tumbull B.W., et al. Effect of selenium supplementation for cancer prevention in patients with carcinoma of skin: a randomized control trial. Nutritional Prevention of Cancer Study Group. JAMA 1996, 276:1957-1963.
54. Clark L.C., Dalkin B., Krongrad A., et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Uro 1998, 81:730-734.